William Liang
Lawyers
![](/sites/default/files/styles/teaser_headshot/public/lawyer-images/32142_wliang_0.jpg?itok=A_fJcFED)
Filters
IDEAYA Biosciences $143.8 million equity offering
The common stock is listed on the Nasdaq Global Select Market
Semtech $250 million convertible senior notes offering
We advised Semtech on its private placement of 4% convertible senior notes due 2028
Coty €500 million senior secured notes offering
The 5.75% senior secured notes are due 2028
Marvell Technology $1 billion senior notes offering
The senior notes are due 2029 and 2033
CSG Systems International $425 million convertible senior notes offering
The 3.875% convertible notes are due 2028
Shockwave Medical $750 million convertible senior notes offering
The 1% convertible notes are due 2028
Fluor $115 million tender offer
The company purchased certain debt securities
Hannon Armstrong $402.5 million exchangeable senior notes offering
The green exchangeable notes are due 2028
Fluor $575 million convertible senior notes offering
The 1.125% notes are due 2029
Immedica Pharma acquisition of pegzilarginase assets from Aeglea
We advised Immedica on the transaction